Skip to content
Menu
Get the app WatchlistsPortfoliosAlerts
Pricing Sign in

Tibet Pharmaceuticals, Inc. TBET

Full chart Compare
Set alert

Price alert · TBET

All alert types
0.00 USD 0.00 (+0.00%)

Regular-session close

0.000001 Day range 0.0001
0.000001 52-week range 0.0001
YTD
0.00%
1 year
0.00%

Included in Essentials and up

Sign in to see Fair value

Discounted cash flow estimates against the price, and the P/E against its industry and sector.

Sign in

Included in Essentials and up

Sign in to see Head count and owner earnings

Employees by annual report and the cash the business earns for its owners.

Sign in

Financial health

Altman Z-Score

2.84 Grey zone

Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.

Piotroski F-Score

5 / 9 Average

Nine pass/fail tests of profitability, leverage and efficiency.

Valuation

P/E 0.0×
FY 2008: 0.0×FY 2009: 0.0×FY 2010: 0.0×
FY 2008 5y median 0.0× FY 2010
P/S 0.0×
FY 2008: 0.0×FY 2009: 0.0×FY 2010: 0.0×
FY 2008 5y median 0.0× FY 2010
P/B 0.0×
FY 2008: 0.0×FY 2009: 0.0×FY 2010: 0.0×
FY 2008 5y median 0.0× FY 2010
P/FCF 0.0×
FY 2008: 0.0×FY 2009: 0.0×FY 2010: 0.0×
FY 2008 5y median 0.0× FY 2010
EV/EBITDA -0.5×
FY 2008: 0.1×FY 2009: -0.0×FY 2010: -0.5×
FY 2008 5y median -0.0× FY 2010
EV/Sales -0.2×
FY 2008: 0.1×FY 2009: -0.0×FY 2010: -0.2×
FY 2008 5y median -0.0× FY 2010
FCF Yield 65239295.3%
FY 2008: 47673002.4%FY 2009: 88798702.6%FY 2010: 65239295.3%
FY 2008 5y median 65239295.3% FY 2010

Profitability

Gross Margin 50.0%
FY 2008: 49.6%FY 2009: 50.9%FY 2010: 50.0%
FY 2008 5y median 50.0% FY 2010
Operating Margin 41.1%
FY 2008: 39.1%FY 2009: 40.9%FY 2010: 41.1%
FY 2008 5y median 40.9% FY 2010
Net Margin 40.6%
FY 2008: 38.1%FY 2009: 40.2%FY 2010: 40.6%
FY 2008 5y median 40.2% FY 2010
ROE 56.0%
FY 2008: 58.9%FY 2009: 87.7%FY 2010: 56.0%
FY 2008 5y median 58.9% FY 2010
ROIC 0.0%
FY 2008: 0.0%FY 2009: 0.0%FY 2010: 0.0%
FY 2008 5y median 0.0% FY 2010
ROA 46.6%
FY 2008: 37.1%FY 2009: 51.5%FY 2010: 46.6%
FY 2008 5y median 46.6% FY 2010

Growth (YoY)

Revenue 40.7%
FY 2008: 0.0%FY 2009: 47.7%FY 2010: 40.7%
FY 2008 FY 2010
Operating Income 41.4%
FY 2008: 0.0%FY 2009: 54.6%FY 2010: 41.4%
FY 2008 FY 2010
EPS (diluted) 40.5%
FY 2008: 0.0%FY 2009: 54.9%FY 2010: 40.5%
FY 2008 FY 2010
Free Cash Flow -25.4%
FY 2008: 0.0%FY 2009: 86.3%FY 2010: -25.4%
FY 2008 FY 2010

Financial Health

Current Ratio 4.5×
FY 2008: 3.1×FY 2009: 2.7×FY 2010: 4.5×
FY 2008 5y median 3.1× FY 2010
Quick Ratio 4.2×
FY 2008: 2.5×FY 2009: 2.3×FY 2010: 4.2×
FY 2008 5y median 2.5× FY 2010
Debt / Equity 0.0×
FY 2008: 0.4×FY 2009: 0.3×FY 2010: 0.0×
FY 2008 5y median 0.3× FY 2010
Net Debt / EBITDA -0.5×
FY 2008: 0.1×FY 2009: -0.0×FY 2010: -0.5×
FY 2008 5y median -0.0× FY 2010
Interest Coverage 71.0×
FY 2008: 34.3×FY 2009: 50.9×FY 2010: 71.0×
FY 2008 5y median 50.9× FY 2010

Dividends

Dividend Yield 21281433.1%
FY 2008: 36485553.4%FY 2009: 75518308.5%FY 2010: 21281433.1%
FY 2008 5y median 36485553.4% FY 2010
Payout Ratio 19.1%
FY 2008: 71.5%FY 2009: 95.0%FY 2010: 19.1%
FY 2008 5y median 71.5% FY 2010

Annual · latest fiscal year ends 2010-12-31